Experimental & Translational Stroke Medicine will cease to be published as of 31st December 2016.

BioMed Central will continue to host an archive of all articles previously published in the journal and all articles published in Experimental & Translational Stroke Medicine will remain fully searchable via the BioMed Central website, as well as through PubMed Central. Experimental & Translational Stroke Medicine is no longer accepting submissions.


View all articles

Most accessed articles

View all articles


Pietro Ghezzi, Brighton and Sussex Medical School, UK

Deputy Editor

Frank C Barone, SUNY Downstate Medical Center, USA

Aims and scope

Experimental & Translational Stroke Medicine is an open access journal presenting original research, review and comment articles on any topic that relates to identifying and solving problems in experimental, translational and clinical stroke research and related cerebrovascular diseases.

By offering a high-visibility forum for new insights and discussions, the journal helps improve the quality of experimental stroke research in order to increase the rate of successful translation of innovative treatment strategies into clinical practice.

ETSM considers studies related to all areas of stroke research, from molecular neuroscience to clinical management and rehabilitation, as well as research on other aspects of cerebrovascular medicine and disease related to stroke and cerebral hypoxia. ETSM welcomes research on topics including but not limited to:

  • Neuroregeneration and repair
  • Stem cell research
  • Neuroprotection
  • Neuroimaging
  • Neuroimmunology
  • Subarachnoid hemorrhage
  • Genome-wide association studies
  • Epidemiology
  • Pharmacology
  • Rehabilitation
  • Physiotherapy and care
  • Occupational therapy
  • Speech-language therapy
  • Stroke complications and disabilities
  • Stroke prevention